IPO Analysis
Sudeep Pharma IPO IPO Analysis: Complete Investment Guide
IpoFly Research Team
Recently
8 min read
Track this IPO: Sudeep Pharma IPO Live GMP →
Sudeep Pharma IPO is ongoing for subscription. This comprehensive analysis covers all aspects including GMP trends, subscription status, financial performance, and AI-powered investment rating to help you make an informed decision.
IPO Details at a Glance
| Parameter | Details |
|---|---|
| Company Name | Sudeep Pharma IPO |
| Issue Size | ₹895.00 Cr |
| Price Band | ₹563.0 - ₹593.0 |
| Lot Size | 25 shares |
| Issue Opens | 21 Nov 2025 |
| Issue Closes | 25 Nov 2025 |
| Listing Date | 28 Nov 2025 |
AI-Powered Investment Rating
AI Investment Rating
⚠️ Neutral
- ❌ Poor subscription levels - very weak investor interest
- ⚠️ Expensive valuation - limited room for gains
- 📈 Moderate listing gains possible (5-12%)
- ⚠️ Average financials - growth could be better
- ⚠️ Average GMP, limited listing gains expected (3-8%)
😊 Apply anytime - Low subscription means high allotment probability
Grey Market Premium (GMP) Analysis
Current GMP
₹111 (18.72%)
GMP %
18.72%
Expected Listing
₹704
Subscription Status
Investment Recommendation
AI Investment Rating
NEUTRAL
- ⚠️ NEUTRAL - Mixed signals, proceed with caution
- Lot Size: Single lot only for diversification
- Bid Price: Bid at CUT-OFF, avoid upper band
- Risk Level: MEDIUM_TO_HIGH
Important Dates
| Event | Date |
|---|---|
| Issue Opens | 21 Nov 2025 |
| Issue Closes | 25 Nov 2025 |
| Allotment | 26 Nov 2025 |
| Listing Date | 28 Nov 2025 |
Investment Disclaimer
This analysis is for informational purposes only. Please consult with a SEBI-registered financial advisor before making investment decisions. Past performance does not guarantee future results.
Tags:
Sudeep Pharma IPOMainboardIPO AnalysisGMPInvestment Guide